Drug Combination Details
| General Information of the Combination (ID: C52995) | |||||
|---|---|---|---|---|---|
| Name | Anidulafungin NP Info | + | Voriconazole Drug Info | ||
| Structure |
|
+ |
|
||
| Disease |
Aspergillosis
[ICD-11: 1F20]
|
Phase 3 | [1] | ||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. Enhancing Drug Efficacy by This Combination | ||||||
| Achieving Therapeutic Synergy | Click to Show/Hide | |||||
| Experiment 1 Reporting the Effect of This Combination | [2] | |||||
| Molecule(s)
Regulation |
Up-regulation | Expression | CYP51A1 | Molecule Info |
Pathway MAP
|
|
| In-vitro Model | Aspergillus fumigatus | Microorganism model | Aspergillus fumigatus | |||
| Experimental
Result(s) |
The combination demonstrated synergy against the VCZ-R clinical isolate as well. | |||||